{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:05:40Z","timestamp":1784826340192,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To report a case with combined pituitary hormone deficiency (CPHD) and Fibroblast growth factor receptor 1 (FGFR1) gene defect, and summarize the clinical characteristics of similar cases by reviewing the current reports from the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A 24-year-old woman was admitted to the outpatient endocrinology unit with a diagnosis of primary amenorrhea, history of Growth Hormone deficiency and multiple congenital anomalies including rectal atresia. The subsequent hormonal investigation led to the diagnosis of hypogonadotropic hypogonadism and persistent GH deficiency. Abdominal and pelvic ultrasounds were normal whereas the brain MRI revealed a hypoplastic sella turcica with a hypoplastic anterior pituitary lobe, an ectopic posterior pituitary lobe and a thin pituitary stalk. The genetic analysis revealed a novel pathogenic missense heterozygous variant (<jats:italic>c.1958G<\/jats:italic>\u2009<jats:italic>&gt;<\/jats:italic>\u2009<jats:italic>A, p.Agr635Gln<\/jats:italic>) in exon 15 of FGFR1 gene. PubMed, Scopus, and Web of Science were searched for the identification of studies reporting cases of CPHD with FGFR1 gene defects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 648 records retrieved, 10 were included in this review. A comprehensive overview of the cases was summarized, and their clinical and genetic characteristics were presented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Although FGFR1 variants have been associated with Kallmann syndrome and isolated hypogonadotropic hypogonadism and recently with CPHD, the patient\u2019s phenotype includes phenotypic alterations not previously described, to the best of our knowledge, within the spectrum of non-reproductive features of either of these entities. Isolated GH deficiency combined with other non-common abnormalities exerts a great possibility for subsequent CPHD manifestation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12020-025-04261-4","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:23:26Z","timestamp":1748399006000},"page":"556-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rare combination of hypogonadotropic hypogonadism, GH deficiency and rectal atresia in a female with an FGFR1 variant: a case report and systematic review of the literature"],"prefix":"10.1007","volume":"89","author":[{"given":"Krystallenia I.","family":"Alexandraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odysseas","family":"Violetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Memi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Fryssira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papagianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"2","key":"4261_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/er.2018-00116","volume":"40","author":"J Young","year":"2019","unstructured":"J. Young, C. Xu, G.E. Papadakis, J.S. Acierno, L. Maione, J. Hietam\u00e4ki et al. Clinical management of congenital hypogonadotropic hypogonadism. Endocr. Rev. 40(2), 669\u2013710 (2019)","journal-title":"Endocr. Rev."},{"key":"4261_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00439-020-02147-1","volume":"140","author":"B Cangiano","year":"2021","unstructured":"B. Cangiano, D.S. Swee, R. Quinton, M. Bonomi, Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease. Hum. Genet. 140, 77\u2013111 (2021)","journal-title":"Hum. Genet."},{"key":"4261_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2015.09.010","volume":"417","author":"MJ McCabe","year":"2015","unstructured":"M.J. McCabe, Y. Hu, L.C. Gregory, C. Gaston-Massuet, K.S. Alatzoglou, J.W. Saldanha et al. Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD). Mol. Cell Endocrinol. 417, 63\u201372 (2015)","journal-title":"Mol. Cell Endocrinol."},{"issue":"4","key":"4261_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ejhg.2009.125","volume":"18","author":"EA Webb","year":"2010","unstructured":"E.A. Webb, M.T. Dattani, Septo-optic dysplasia. Eur. J. Hum. Genet. 18(4), 393\u2013397 (2010)","journal-title":"Eur. J. Hum. Genet."},{"key":"4261_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000341733","volume":"23","author":"RE Bancalari","year":"2012","unstructured":"R.E. Bancalari L.C. Gregory, M.J. McCabe, M.T. Dattani, Pituitary gland development: an update. Endocr. Dev. 23, 1\u201315 (2012)","journal-title":"Endocr. Dev."},{"key":"4261_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-416021-7.00001-8","volume":"106","author":"SW Davis","year":"2013","unstructured":"S.W. Davis, B.S. Ellsworth, M.I. Per\u00e9z Millan, P. Gergics, V. Schade, N. Foyouzi et al. Pituitary gland development and disease: from stem cell to hormone production. Curr. Top. Dev. Biol. 106, 1\u201347 (2013)","journal-title":"Curr. Top. Dev. Biol."},{"issue":"6","key":"4261_CR7","doi-asserted-by":"publisher","first-page":"dgz184","DOI":"10.1210\/clinem\/dgz184","volume":"105","author":"LC Gregory","year":"2020","unstructured":"L.C. Gregory, M.T. Dattani, The molecular basis of congenital hypopituitarism and related disorders. J. Clin. Endocrinol. Metab. 105(6), dgz184 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4261_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.metabol.2017.10.012","volume":"86","author":"MI Stamou","year":"2018","unstructured":"M.I. Stamou, N.A. Georgopoulos, Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metabolism 86, 124\u2013134 (2018)","journal-title":"Metabolism"},{"issue":"3","key":"4261_CR9","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1530\/EJE-17-0749","volume":"178","author":"L Maione","year":"2018","unstructured":"L. Maione, A.A. Dwyer, B. Francou, A. Guiochon-Mantel, N. Binart, J. Bouligand et al. GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing. Eur. J. Endocrinol. 178(3), R55\u2013R80 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"4261_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41574-020-00437-2","volume":"17","author":"F Prodam","year":"2021","unstructured":"F. Prodam, M. Caputo, C. Mele, P. Marzullo, G. Aimaretti, Insights into non-classic and emerging causes of hypopituitarism. Nat. Rev. Endocrinol. 17(2), 114\u2013129 (2021)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4261_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021)","journal-title":"BMJ"},{"issue":"7","key":"4261_CR12","doi-asserted-by":"publisher","first-page":"e220504","DOI":"10.1530\/EC-22-0504","volume":"12","author":"KCJ Yuen","year":"2023","unstructured":"K.C.J. Yuen, G. Johannsson, K.K.Y. Ho, B.S. Miller, I. Bergada, A.D. Rogol, Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis. Endocr. Connect. 12(7), e220504 (2023)","journal-title":"Endocr. Connect."},{"issue":"20","key":"4261_CR13","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.3390\/jcm13206079","volume":"13","author":"LS Aversa","year":"2024","unstructured":"L.S. Aversa, D. Cuboni, S. Grottoli, E. Ghigo, V. Gasco, A 2024 update on growth hormone deficiency syndrome in adults: from guidelines to real life. J. Clin. Med. 13(20), 6079 (2024)","journal-title":"J. Clin. Med."},{"issue":"5","key":"4261_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","volume":"31","author":"L Webber","year":"2016","unstructured":"The ESHRE Guideline Group on POI, L. Webber, M. Davies, R. Anderson, J. Bartlett, D. Braat et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum. Reprod. 31(5), 926\u2013937 (2016)","journal-title":"Hum. Reprod."},{"issue":"5","key":"4261_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"R. Eastell, C.J. Rosen, D.M. Black, A.M. Cheung, M.H. Murad, D. Shoback, Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 104(5), 1595\u20131622 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4261_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tem.2010.01.004","volume":"21","author":"Y Hu","year":"2010","unstructured":"Y. Hu, P.M. Bouloux, Novel insights in FGFR1 regulation: lessons from Kallmann syndrome. Trends Endocrinol. Metab. 21(6), 385\u2013393 (2010)","journal-title":"Trends Endocrinol. Metab."},{"key":"4261_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000312693","volume":"39","author":"C Villanueva","year":"2010","unstructured":"C. Villanueva, N. de Roux, FGFR1 mutations in Kallmann syndrome. Front. Horm. Res. 39, 51\u201361 (2010)","journal-title":"Front. Horm. Res."},{"issue":"4","key":"4261_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ajmg.10295","volume":"108","author":"S Vermeulen","year":"2002","unstructured":"S. Vermeulen, L. Messiaen, P. Scheir, S. De Bie, F. Speleman, A. De Paepe, Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion. Am. J. Med. Genet. 108(4), 315\u2013318 (2002)","journal-title":"Am. J. Med. Genet."},{"issue":"8","key":"4261_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1507\/endocrj.EJ13-0023","volume":"60","author":"M Fukami","year":"2013","unstructured":"M. Fukami, M. Iso, N. Sato, M. Igarashi, M. Seo, I. Kazukawa, E. Kinoshita, S. Dateki, T. Ogata, Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency. Endocr. J. 60(8), 1013\u20131020 (2013)","journal-title":"Endocr. J."},{"issue":"2","key":"4261_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1530\/EC-15-0015","volume":"4","author":"FA Correa","year":"2015","unstructured":"F.A. Correa, E.B. Trarbach, C. Tusset et al. FGFR1 and PROKR2 rare variants found in patients with combined pituitary hormone deficiencies. Endocr. Connect. 4(2), 100\u2013107 (2015)","journal-title":"Endocr. Connect."},{"key":"4261_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1334610","volume":"12","author":"A Lyra","year":"2024","unstructured":"A. Lyra, I.F. Rodart, L. Barros, T.S.E. Silva, A.J. da Rocha, C. Kochi et al. Trio-based whole exome sequencing in patients with ectopic posterior pituitary. Front. Pediatr. 12, 1334610 (2024)","journal-title":"Front. Pediatr."},{"issue":"12","key":"4261_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1515\/jpem-2020-0029","volume":"33","author":"Erba\u015f","year":"2020","unstructured":"Erba\u015f, \u0130M, A. Paket\u00e7i, S. Acar, L.D. Kotan, K. Demir, A. Abac\u0131 et al. A nonsense variant in FGFR1: a rare cause of combined pituitary hormone deficiency. J. Pediatr. Endocrinol. Metab. 33(12), 1613\u20131615 (2020)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"7","key":"4261_CR23","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1210\/clinem\/dgab177","volume":"106","author":"SA Vishnopolska","year":"2021","unstructured":"S.A. Vishnopolska, M.F. Mercogliano, M.A. Camilletti, A.H. Mortensen, D. Braslavsky, A. Keselman et al. Comprehensive identification of pathogenic gene variants in patients with neuroendocrine disorders. J. Clin. Endocrinol. Metab. 106(7), 1956\u20131976 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4261_CR24","doi-asserted-by":"publisher","first-page":"E694","DOI":"10.1210\/jc.2011-2938","volume":"97","author":"T Raivio","year":"2012","unstructured":"T. Raivio, M. Avbelj, M.J. McCabe, C.J. Romero, A.A. Dwyer, J. Tommiska et al. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J. Clin. Endocrinol. Metab. 97(4), E694\u2013E699 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4261_CR25","first-page":"P-P2-266","volume":"89","author":"G Tornese","year":"2018","unstructured":"G. Tornese, M.C. Pellegrin, M. Pavan, E. Faleschini, E. Barbi, A Novel FGFR1 mutation in kallmann syndrome with growth hormone deficiency. ESPE Abstr. 89, P-P2-266 (2018)","journal-title":"ESPE Abstr."},{"issue":"3","key":"4261_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1297\/cpe.2022-0020","volume":"31","author":"S Sano","year":"2022","unstructured":"S. Sano, Y. Masunaga, F. Kato, Y. Fujisawa, H. Saitsu, T. Ogata, Combined pituitary hormone deficiency in a patient with an FGFR1 missense variant: case report and literature review. Clin. Pediatr. Endocrinol. 31(3), 172\u2013177 (2022)","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"4261_CR27","first-page":"P2","volume":"97","author":"P Cavallaro","year":"2023","unstructured":"P. Cavallaro, M.F. Messina, T. Aversa, G. Pepe, M. Wasniewska, D. Corica, Combined pituitary hormone deficiency caused by a missense de novo variant in FGFR1. ESPE Abstr. 97, P2\u2013P38 (2023)","journal-title":"ESPE Abstr."},{"issue":"2","key":"4261_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14310\/horm.2002.1346","volume":"11","author":"M Doknic","year":"2012","unstructured":"M. Doknic, S. Pekic, M. Civcic, V. Popovic, Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: from an adult endocrinologist perspective. Hormones (Athens) 11(2), 189\u2013198 (2012)","journal-title":"Hormones (Athens)"},{"issue":"1","key":"4261_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1297\/cpe.2022-0060","volume":"32","author":"N Uchida","year":"2023","unstructured":"N. Uchida, Y. Mizuno, S. Seno, Y. Koyama, T. Takahashi, H. Shibata et al. A novel missense variant of FGFR1 in a Japanese girl with Kallmann syndrome and holoprosencephaly. Clin. Pediatr. Endocrinol. 32(1), 79\u201381 (2023)","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"4261_CR30","doi-asserted-by":"publisher","first-page":"600962","DOI":"10.3389\/fped.2020.600962","volume":"8","author":"L Bosch I Ara","year":"2021","unstructured":"L. Bosch I Ara, H. Katugampola, M.T. Dattani, Congenital hypopituitarism during the neonatal period: epidemiology, pathogenesis, therapeutic options, and outcome. Front. Pediatr. 8, 600962 (2021)","journal-title":"Front. Pediatr."},{"key":"4261_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ghir.2017.10.005","volume":"37","author":"M Cerbone","year":"2017","unstructured":"M. Cerbone, M.T. Dattani, Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency. Growth Horm. IGF Res. 37, 19\u201325 (2017)","journal-title":"Growth Horm. IGF Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04261-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:55:31Z","timestamp":1757174131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04261-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4261"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04261-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local institutional ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained by the patient for the publication of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}